ness. A total of 214 patients were classified into 17 autoimmune diseases based on their symptoms at the initial visit, while the other 95 patients did not meet any criteria. Most of the 214 patients were diagnosed with SSc and/or SS; 25 and 22 additional patients were diagnosed with rheumatoid arthritis and PBC, respectively.
Higher titers of immunoglobulins were observed in patients diagnosed with autoimmune disease compared to patients without a diagnosis. The mean observation period was 80 months. Three additional patients received interim diagnoses based on new symptoms or organ involvement. In the other patients, the diagnosis made at the first visit was not changed over the observation period.
Conclusion:
Our study confirmed that many ACA-positive cases can be classified into an autoimmune disease type on presentation.
K E Y W O R D S
antibodies, anti-nuclear/BL, centromere/IM, Sjögren's syndrome, systemic sclerosis Results of laboratory tests including immunoglobulin (Ig) and serum autoantibody levels were available. The clinical characteristics of the patients were collected from their medical records.
| Statistical analysis
We used commercial statistical software (JMP 13 system®, SAS Institute Inc, Cary, NC, USA) to conduct statistical analysis. The
Wilcoxon rank sum test was used to assess the statistical significance of differences between groups. Dunn's test was used for multiple comparison procedures. A P value < 0.05 was considered statistically significant.
| RE SULTS

| Additional ANA patterns
This study included 309 patients with discrete-speckled pattern on ANA testing or ACA positivity. The proportion of cases with 2 or 3
ANA patterns is shown in Figure 1 . More than 2/3 of the patients had the centromere pattern alone and 1/3 had both the centromere pattern and other patterns. The most common 2nd pattern was the speckled pattern.
| Characteristics of patients at initial visit
Clinical characteristics of the patients at the initial visit are shown in Table 1 . This study included 17 men (6%) and 292 women (94%).
Mean age was 60 ± 12 years (range, 19-86). A total of 186 patients (60%) had Raynaud's phenomenon, 149 (48%) had sclerodactyly, and 162 (52%) had oral and/or ocular dryness symptoms.
A total of 214 patients (69%) were classified into 17 autoimmune diseases (including overlap cases) using symptoms presented at the initial visit, while the other 95 patients (31%) did not meet any specific diagnostic criteria. The frequency of Raynaud's phenomenon and sclerodactyly in patients who were diagnosed with autoimmune disease was higher than that in the other patients (P < 0.01 and P < 0.01, respectively). The titers of IgG, IgM, and
IgA in diagnosed patients were higher than those in patients who did not meet any diagnostic criteria (P < 0.01, P < 0.01 and P = 0.016, respectively).
| Diagnosis at initial presentation
The diagnoses at initial presentation in 309 patients are shown in Table 2 . Among the diagnosed patients (n = 214, 69%), most
were diagnosed with SSc (n = 113, 36%) and/or SS (n = 78, 25%).
An additional 25 (8%) and 22 patients (7%) were diagnosed with RA and PBC, respectively. Three patients (1%) were diagnosed with SLE. Figure 2 shows the relationship between diagnosis and the patients' ANA patterns. The 4 major diseases diagnosed at initial presentation in patients are shown. was similar among all patterns. The proportion of SS patients was higher among those with the centromere pattern plus a speckled or cytoplasmic pattern.
| Change of diagnosis over the observation period
The mean observation period was 80 months. Two of the 95 patients who were undiagnosed at the initial visit were diagnosed during observation: a 70-year-old woman was diagnosed with autoimmune 
| D ISCUSS I ON
In this study, 2/3 of ACA-positive cases were classified into various autoimmune disease types at 1st presentation. Few patients had new symptoms during observation, and the initial diagnosis was unchanged in most patients.
Anti-centromere antibodies recognizes several types of centromere proteins (CENP). 2 ACA is often detected in patients with autoimmune diseases, such as limited cutaneous SSc and PBC. In our study, 30% of ACA-positive patients did not fall into a discrete diagnostic category, while the others were classified into 17 autoimmune diseases, including overlap cases, using symptoms and laboratory results obtained at the initial visit. ACA has been detected in sera from SSc, SS, SLE, PBC, and RA cases, but at unknown frequencies. 2 In our study, we showed new clinical entities in ACApositive cases.
Patients diagnosed with autoimmune diseases had Raynaud's phenomenon and sclerodactyly similar to SSc patients, as well as anemia, thrombocytopenia, and high titer of immunoglobulin similar to SS. The frequency of SLE, including overlap cases, was low, similar to that of other minor diseases, such as small or large vessel vasculitis and AIH.
The diagnosis from initial manifestation in most patients was not changed and only 3 new diagnoses were added during observation.
We evaluated the patients' diagnoses with the latest classification criteria because using the criteria at the time that patients initially visited our hospital might cause confusion in this study. The newly published classification criteria have good sensitivity, and we suspect that the findings on presentation easily matched the criteria, 6, 7 allowing for prompt diagnosis.
We note two limitations of our study. First, the number of patients was relatively small and from a single center, although it was large enough to provide statistically significant data. Second, we did not identify the specific CENP antigen in each ACA-positive patient.
A past report showed an association between CENP patterns and specific diseases. 
| CON CLUS ION
Our retrospective cohort study confirmed that the majority of ACApositive cases were easily classified into various types of autoimmune diseases. Few patients had new symptoms during observation, and the initial diagnosis was unchanged in most patients. Our data demonstrate that initial presentation often determines the diagnosis in patients with ACA positivity.
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